June 19, 2020 / 7:13 AM / a month ago

BRIEF-3Sbio Inc Says Approval Obtained For Inetetamab, First Innovative Anti-Her2 Monoclonal Antibody

June 19 (Reuters) - 3SBio Inc:

* 3SBIO INC - APPROVAL OBTAINED FOR INETETAMAB, FIRST INNOVATIVE ANTI-HER2 MONOCLONAL ANTIBODY

* 3SBIO INC - GOT APPROVAL FROM NMPA OF PRC FOR INETETAMAB Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below